APP and Alzheimer disease: Genes involved in cholesterol biosynthesis and metabolic pathways (Scd2, Sqle, Hmgcs1, and Hmgcr) and genes relevant to AD (App, Ppp3cb, Atp2a2, Calm2, and Scna) were also downregulated (Supplementary Data 2).